Catecholamines act via a β-adrenergic receptor to maintain fetal heart rate and survival

Mice lacking catecholamines die before birth, some with cardiovascular abnormalities. To investigate the role of catecholamines in development, embryonic day 12.5 (E12.5) fetuses were cultured and heart rate monitored. Under optimal oxygenation, wild-type and catecholamine-deficient fetuses had the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2003-06, Vol.53 (6), p.H2069-H2077
Hauptverfasser: PORTBURY, Andrea L, CHANDRA, Rashmi, GROELLE, Marybeth, MCMILLIAN, Michael K, ELIAS, Alana, HERLONG, James R, RIOS, Maribel, ROFFLER-TARLOV, Suzanne, CHIKARAISHI, Dona M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page H2077
container_issue 6
container_start_page H2069
container_title American journal of physiology. Heart and circulatory physiology
container_volume 53
creator PORTBURY, Andrea L
CHANDRA, Rashmi
GROELLE, Marybeth
MCMILLIAN, Michael K
ELIAS, Alana
HERLONG, James R
RIOS, Maribel
ROFFLER-TARLOV, Suzanne
CHIKARAISHI, Dona M
description Mice lacking catecholamines die before birth, some with cardiovascular abnormalities. To investigate the role of catecholamines in development, embryonic day 12.5 (E12.5) fetuses were cultured and heart rate monitored. Under optimal oxygenation, wild-type and catecholamine-deficient fetuses had the same initial heart rate (200-220 beats/min), which decreased by 15% in wild-type fetuses during 50 min of culture. During the same culture period, catecholamine-deficient fetuses dropped their heart rate by 35%. Hypoxia reduced heart rate of wild-type fetuses by 35-40% in culture and by 20% in utero, assessed by echocardiography. However, catecholamine-deficient fetuses exhibited greater hypoxia-induced bradycardia, reducing their heart rate by 70-75% in culture. Isoproterenol, a beta-adrenergic receptor (beta-AR) agonist, reversed this extreme bradycardia, restoring the rate of catecholamine-deficient fetuses to that of nonmutant siblings. Moreover, isoproterenol rescued 100% of catecholamine-deficient pups to birth in a dose-dependent, stereo-specific manner when administered in the dam's drinking water. An beta-AR agonist was without effect. When wild-type fetuses were cultured with adrenoreceptor antagonists to create pharmacological nulls, blockade of beta-ARs with 10 microM phentolamine or -ARs with 10 microM bupranolol alone or in combination did not reduce heart rate under optimal oxygenation. However, when combined with hypoxia, beta-AR blockade reduced heart rate by 35%. In contrast, the muscarinic blocker atropine and the -AR antagonist phentolamine had no effect. These data suggest that beta-ARs mediate survival in vivo and regulate heart rate in culture. We hypothesize that norepinephrine, acting through beta-ARs, maintains fetal heart rate during periods of transient hypoxia that occur throughout gestation, and that catecholamine-deficient fetuses die because they cannot withstand hypoxia-induced bradycardia. [PUBLICATION ABSTRACT]
format Article
fullrecord <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_proquest_journals_229596334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>670169141</sourcerecordid><originalsourceid>FETCH-LOGICAL-p574-40d8aef1d4a50c987edc8f0db55875ec5a8ba8590373a7b3311bc72dd3321dea3</originalsourceid><addsrcrecordid>eNotjc1KxDAURoMoOI6-QxBcFpLepkmXUvyDATezcVVuk1snQ_9M0gFfywfxmSw4i4-zOZzvgm2kyvNMKqgu2UZACVkpQV2zmxiPQgilS9iwjxoT2cPU4-BHihxt4iePHPnvT4Yu0Ejh01seyNKcpsDTxAf0Y1rHO0rY8wNhSDysHY6j43EJJ3_C_pZdddhHujtzy_bPT_v6Ndu9v7zVj7tsVrrICuEMUiddgUrYymhy1nTCtUoZrcgqNC0aVQnQgLoFkLK1OncOIJeOELbs_j87h-lroZia47SEcX1s8rxSVQlQrNLDWcJose8CjtbHZg5-wPDdyEJXWhsFf_Q0XLk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229596334</pqid></control><display><type>article</type><title>Catecholamines act via a β-adrenergic receptor to maintain fetal heart rate and survival</title><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>PORTBURY, Andrea L ; CHANDRA, Rashmi ; GROELLE, Marybeth ; MCMILLIAN, Michael K ; ELIAS, Alana ; HERLONG, James R ; RIOS, Maribel ; ROFFLER-TARLOV, Suzanne ; CHIKARAISHI, Dona M</creator><creatorcontrib>PORTBURY, Andrea L ; CHANDRA, Rashmi ; GROELLE, Marybeth ; MCMILLIAN, Michael K ; ELIAS, Alana ; HERLONG, James R ; RIOS, Maribel ; ROFFLER-TARLOV, Suzanne ; CHIKARAISHI, Dona M</creatorcontrib><description>Mice lacking catecholamines die before birth, some with cardiovascular abnormalities. To investigate the role of catecholamines in development, embryonic day 12.5 (E12.5) fetuses were cultured and heart rate monitored. Under optimal oxygenation, wild-type and catecholamine-deficient fetuses had the same initial heart rate (200-220 beats/min), which decreased by 15% in wild-type fetuses during 50 min of culture. During the same culture period, catecholamine-deficient fetuses dropped their heart rate by 35%. Hypoxia reduced heart rate of wild-type fetuses by 35-40% in culture and by 20% in utero, assessed by echocardiography. However, catecholamine-deficient fetuses exhibited greater hypoxia-induced bradycardia, reducing their heart rate by 70-75% in culture. Isoproterenol, a beta-adrenergic receptor (beta-AR) agonist, reversed this extreme bradycardia, restoring the rate of catecholamine-deficient fetuses to that of nonmutant siblings. Moreover, isoproterenol rescued 100% of catecholamine-deficient pups to birth in a dose-dependent, stereo-specific manner when administered in the dam's drinking water. An beta-AR agonist was without effect. When wild-type fetuses were cultured with adrenoreceptor antagonists to create pharmacological nulls, blockade of beta-ARs with 10 microM phentolamine or -ARs with 10 microM bupranolol alone or in combination did not reduce heart rate under optimal oxygenation. However, when combined with hypoxia, beta-AR blockade reduced heart rate by 35%. In contrast, the muscarinic blocker atropine and the -AR antagonist phentolamine had no effect. These data suggest that beta-ARs mediate survival in vivo and regulate heart rate in culture. We hypothesize that norepinephrine, acting through beta-ARs, maintains fetal heart rate during periods of transient hypoxia that occur throughout gestation, and that catecholamine-deficient fetuses die because they cannot withstand hypoxia-induced bradycardia. [PUBLICATION ABSTRACT]</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>CODEN: AJPPDI</identifier><language>eng</language><publisher>Bethesda, MD: American Physiological Society</publisher><subject>Biological and medical sciences ; Blood pressure ; Cardiology ; Cardiovascular disease ; Embryology: invertebrates and vertebrates. Teratology ; Fundamental and applied biological sciences. Psychology ; Hormones ; Organogenesis. Physiological fonctions ; Physiological fonctions ; Prenatal development ; Rodents</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2003-06, Vol.53 (6), p.H2069-H2077</ispartof><rights>2003 INIST-CNRS</rights><rights>Copyright American Physiological Society Jun 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14797785$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>PORTBURY, Andrea L</creatorcontrib><creatorcontrib>CHANDRA, Rashmi</creatorcontrib><creatorcontrib>GROELLE, Marybeth</creatorcontrib><creatorcontrib>MCMILLIAN, Michael K</creatorcontrib><creatorcontrib>ELIAS, Alana</creatorcontrib><creatorcontrib>HERLONG, James R</creatorcontrib><creatorcontrib>RIOS, Maribel</creatorcontrib><creatorcontrib>ROFFLER-TARLOV, Suzanne</creatorcontrib><creatorcontrib>CHIKARAISHI, Dona M</creatorcontrib><title>Catecholamines act via a β-adrenergic receptor to maintain fetal heart rate and survival</title><title>American journal of physiology. Heart and circulatory physiology</title><description>Mice lacking catecholamines die before birth, some with cardiovascular abnormalities. To investigate the role of catecholamines in development, embryonic day 12.5 (E12.5) fetuses were cultured and heart rate monitored. Under optimal oxygenation, wild-type and catecholamine-deficient fetuses had the same initial heart rate (200-220 beats/min), which decreased by 15% in wild-type fetuses during 50 min of culture. During the same culture period, catecholamine-deficient fetuses dropped their heart rate by 35%. Hypoxia reduced heart rate of wild-type fetuses by 35-40% in culture and by 20% in utero, assessed by echocardiography. However, catecholamine-deficient fetuses exhibited greater hypoxia-induced bradycardia, reducing their heart rate by 70-75% in culture. Isoproterenol, a beta-adrenergic receptor (beta-AR) agonist, reversed this extreme bradycardia, restoring the rate of catecholamine-deficient fetuses to that of nonmutant siblings. Moreover, isoproterenol rescued 100% of catecholamine-deficient pups to birth in a dose-dependent, stereo-specific manner when administered in the dam's drinking water. An beta-AR agonist was without effect. When wild-type fetuses were cultured with adrenoreceptor antagonists to create pharmacological nulls, blockade of beta-ARs with 10 microM phentolamine or -ARs with 10 microM bupranolol alone or in combination did not reduce heart rate under optimal oxygenation. However, when combined with hypoxia, beta-AR blockade reduced heart rate by 35%. In contrast, the muscarinic blocker atropine and the -AR antagonist phentolamine had no effect. These data suggest that beta-ARs mediate survival in vivo and regulate heart rate in culture. We hypothesize that norepinephrine, acting through beta-ARs, maintains fetal heart rate during periods of transient hypoxia that occur throughout gestation, and that catecholamine-deficient fetuses die because they cannot withstand hypoxia-induced bradycardia. [PUBLICATION ABSTRACT]</description><subject>Biological and medical sciences</subject><subject>Blood pressure</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Embryology: invertebrates and vertebrates. Teratology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hormones</subject><subject>Organogenesis. Physiological fonctions</subject><subject>Physiological fonctions</subject><subject>Prenatal development</subject><subject>Rodents</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNotjc1KxDAURoMoOI6-QxBcFpLepkmXUvyDATezcVVuk1snQ_9M0gFfywfxmSw4i4-zOZzvgm2kyvNMKqgu2UZACVkpQV2zmxiPQgilS9iwjxoT2cPU4-BHihxt4iePHPnvT4Yu0Ejh01seyNKcpsDTxAf0Y1rHO0rY8wNhSDysHY6j43EJJ3_C_pZdddhHujtzy_bPT_v6Ndu9v7zVj7tsVrrICuEMUiddgUrYymhy1nTCtUoZrcgqNC0aVQnQgLoFkLK1OncOIJeOELbs_j87h-lroZia47SEcX1s8rxSVQlQrNLDWcJose8CjtbHZg5-wPDdyEJXWhsFf_Q0XLk</recordid><startdate>20030601</startdate><enddate>20030601</enddate><creator>PORTBURY, Andrea L</creator><creator>CHANDRA, Rashmi</creator><creator>GROELLE, Marybeth</creator><creator>MCMILLIAN, Michael K</creator><creator>ELIAS, Alana</creator><creator>HERLONG, James R</creator><creator>RIOS, Maribel</creator><creator>ROFFLER-TARLOV, Suzanne</creator><creator>CHIKARAISHI, Dona M</creator><general>American Physiological Society</general><scope>IQODW</scope><scope>7QP</scope><scope>7QR</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20030601</creationdate><title>Catecholamines act via a β-adrenergic receptor to maintain fetal heart rate and survival</title><author>PORTBURY, Andrea L ; CHANDRA, Rashmi ; GROELLE, Marybeth ; MCMILLIAN, Michael K ; ELIAS, Alana ; HERLONG, James R ; RIOS, Maribel ; ROFFLER-TARLOV, Suzanne ; CHIKARAISHI, Dona M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p574-40d8aef1d4a50c987edc8f0db55875ec5a8ba8590373a7b3311bc72dd3321dea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Biological and medical sciences</topic><topic>Blood pressure</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Embryology: invertebrates and vertebrates. Teratology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hormones</topic><topic>Organogenesis. Physiological fonctions</topic><topic>Physiological fonctions</topic><topic>Prenatal development</topic><topic>Rodents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PORTBURY, Andrea L</creatorcontrib><creatorcontrib>CHANDRA, Rashmi</creatorcontrib><creatorcontrib>GROELLE, Marybeth</creatorcontrib><creatorcontrib>MCMILLIAN, Michael K</creatorcontrib><creatorcontrib>ELIAS, Alana</creatorcontrib><creatorcontrib>HERLONG, James R</creatorcontrib><creatorcontrib>RIOS, Maribel</creatorcontrib><creatorcontrib>ROFFLER-TARLOV, Suzanne</creatorcontrib><creatorcontrib>CHIKARAISHI, Dona M</creatorcontrib><collection>Pascal-Francis</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PORTBURY, Andrea L</au><au>CHANDRA, Rashmi</au><au>GROELLE, Marybeth</au><au>MCMILLIAN, Michael K</au><au>ELIAS, Alana</au><au>HERLONG, James R</au><au>RIOS, Maribel</au><au>ROFFLER-TARLOV, Suzanne</au><au>CHIKARAISHI, Dona M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Catecholamines act via a β-adrenergic receptor to maintain fetal heart rate and survival</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><date>2003-06-01</date><risdate>2003</risdate><volume>53</volume><issue>6</issue><spage>H2069</spage><epage>H2077</epage><pages>H2069-H2077</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><coden>AJPPDI</coden><abstract>Mice lacking catecholamines die before birth, some with cardiovascular abnormalities. To investigate the role of catecholamines in development, embryonic day 12.5 (E12.5) fetuses were cultured and heart rate monitored. Under optimal oxygenation, wild-type and catecholamine-deficient fetuses had the same initial heart rate (200-220 beats/min), which decreased by 15% in wild-type fetuses during 50 min of culture. During the same culture period, catecholamine-deficient fetuses dropped their heart rate by 35%. Hypoxia reduced heart rate of wild-type fetuses by 35-40% in culture and by 20% in utero, assessed by echocardiography. However, catecholamine-deficient fetuses exhibited greater hypoxia-induced bradycardia, reducing their heart rate by 70-75% in culture. Isoproterenol, a beta-adrenergic receptor (beta-AR) agonist, reversed this extreme bradycardia, restoring the rate of catecholamine-deficient fetuses to that of nonmutant siblings. Moreover, isoproterenol rescued 100% of catecholamine-deficient pups to birth in a dose-dependent, stereo-specific manner when administered in the dam's drinking water. An beta-AR agonist was without effect. When wild-type fetuses were cultured with adrenoreceptor antagonists to create pharmacological nulls, blockade of beta-ARs with 10 microM phentolamine or -ARs with 10 microM bupranolol alone or in combination did not reduce heart rate under optimal oxygenation. However, when combined with hypoxia, beta-AR blockade reduced heart rate by 35%. In contrast, the muscarinic blocker atropine and the -AR antagonist phentolamine had no effect. These data suggest that beta-ARs mediate survival in vivo and regulate heart rate in culture. We hypothesize that norepinephrine, acting through beta-ARs, maintains fetal heart rate during periods of transient hypoxia that occur throughout gestation, and that catecholamine-deficient fetuses die because they cannot withstand hypoxia-induced bradycardia. [PUBLICATION ABSTRACT]</abstract><cop>Bethesda, MD</cop><pub>American Physiological Society</pub></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 2003-06, Vol.53 (6), p.H2069-H2077
issn 0363-6135
1522-1539
language eng
recordid cdi_proquest_journals_229596334
source American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Biological and medical sciences
Blood pressure
Cardiology
Cardiovascular disease
Embryology: invertebrates and vertebrates. Teratology
Fundamental and applied biological sciences. Psychology
Hormones
Organogenesis. Physiological fonctions
Physiological fonctions
Prenatal development
Rodents
title Catecholamines act via a β-adrenergic receptor to maintain fetal heart rate and survival
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T04%3A56%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Catecholamines%20act%20via%20a%20%CE%B2-adrenergic%20receptor%20to%20maintain%20fetal%20heart%20rate%20and%20survival&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=PORTBURY,%20Andrea%20L&rft.date=2003-06-01&rft.volume=53&rft.issue=6&rft.spage=H2069&rft.epage=H2077&rft.pages=H2069-H2077&rft.issn=0363-6135&rft.eissn=1522-1539&rft.coden=AJPPDI&rft_id=info:doi/&rft_dat=%3Cproquest_pasca%3E670169141%3C/proquest_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229596334&rft_id=info:pmid/&rfr_iscdi=true